Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00604552 · ClinicalTrials.gov registry record · NA
AneuRx Post Market Study in the Treatment of AAA
A NA study, sponsored by Medtronic Cardiovascular.
- Terminated
- Registry status
- NA
- Development phase
- 349
- Enrollment target
NCT00604552: Clinical Trial NA study, sponsored by Medtronic Cardiovascular.
NCT00604552 is a NA study that was terminated before completion, run by Medtronic Cardiovascular. The registered enrollment target is 349 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00604552, a NA study, was terminated before completion, sponsored by Medtronic Cardiovascular.
- TERMINATED
- Registry status
- NA
- Development phase
- 349 participants
- Enrollment target
Study Summary
The aorta is a large blood vessel that carries blood away from the heart to the organs in the rest of the body. An aneurysm is a weakening in the artery wall that will become a bulge in the aorta. If left untreated, this bulge may continue to grow larger and may rupture (break open) with fatal consequences. Abdominal aortic aneurysm (AAA) is a life-threatening lesion that has been treated in recent year via endovascular repair. The purpose of this study is to monitor the long term performance of the AneuRx Stent Graft Systems.
Primary Outcome
Number of patients that had an occurrence of death, aneurysm rupture or surgical conversion
Interventions
- DEVICE AneuRx Stent Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2003-07 |
| Est. Completion | 2009-02 |
| Phase | NA |
Why NCT00604552 stopped before completion
NCT00604552 is an interventional study that assigns participants to a tested intervention. The registered 349 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 1 intervention - of which AneuRx Stent Graft is the first listed.
NCT00604552 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00604552 about?
NCT00604552 is a clinical study titled "AneuRx Post Market Study in the Treatment of AAA". The aorta is a large blood vessel that carries blood away from the heart to the organs in the rest of the body. An aneurysm is a weakening in the artery wall that will become a bulge in the aorta. If left untreated, this bulge may continue to grow larger and may rupture (break open) with fatal conse...
What is the current status of trial NCT00604552?
This trial is currently terminated. It is a NA study. The enrollment target is 349 participants. The study started on 2003-07. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00604552?
The interventions under investigation include: AneuRx Stent Graft (DEVICE).
Who is sponsoring clinical trial NCT00604552?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00604552's enrollment target sits among peer trials
349 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia